These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


155 related items for PubMed ID: 1700335

  • 1. Why are eye muscles frequently involved in myasthenia gravis?
    Kaminski HJ, Maas E, Spiegel P, Ruff RL.
    Neurology; 1990 Nov; 40(11):1663-9. PubMed ID: 1700335
    [No Abstract] [Full Text] [Related]

  • 2. Acetylcholine receptor epitopes in ocular myasthenia.
    Kaminski HJ.
    Ann N Y Acad Sci; 1998 May 13; 841():309-19. PubMed ID: 9668249
    [No Abstract] [Full Text] [Related]

  • 3. Ocular myasthenia gravis. A critical review of clinical and pathophysiological aspects.
    Sommer N, Melms A, Weller M, Dichgans J.
    Doc Ophthalmol; 1993 May 13; 84(4):309-33. PubMed ID: 8156854
    [Abstract] [Full Text] [Related]

  • 4. Transient neonatal myasthenia gravis in a baby born to a mother with new-onset anti-MuSK-mediated myasthenia gravis.
    O'carroll P, Bertorini TE, Jacob G, Mitchell CW, Graff J.
    J Clin Neuromuscul Dis; 2009 Dec 13; 11(2):69-71. PubMed ID: 19955986
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Ocular presentation of myasthenia gravis: A natural history cohort.
    Kamarajah SK, Sadalage G, Palmer J, Carley H, Maddison P, Sivaguru A.
    Muscle Nerve; 2018 Apr 13; 57(4):622-627. PubMed ID: 28881457
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Serum acetylcholine receptor antibody measurement in myasthenia gravis. Some trials to background radioactivity in radioimmunoassay.
    Buot WL, Goto I, Oda K, Kuroiwa Y.
    J Neurol Sci; 1982 Apr 13; 57(1):111-20. PubMed ID: 6185642
    [No Abstract] [Full Text] [Related]

  • 10. Is "seronegative" MG explained by autoantibodies to MuSK?
    Vincent AC, McConville J, Newsom-Davis J.
    Neurology; 2005 Jan 25; 64(2):399; author reply 399. PubMed ID: 15668461
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A 17-Mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravis.
    Yoshikawa H, Lambert EH, Walser-Kuntz DR, Yasukawa Y, McCormick DJ, Lennon VA.
    J Immunol; 1997 Aug 01; 159(3):1570-7. PubMed ID: 9233656
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Myasthenia gravis.
    Sen S, Banerjee TK.
    J Assoc Physicians India; 1995 Jul 01; 43(7):487-93. PubMed ID: 8713224
    [No Abstract] [Full Text] [Related]

  • 16. Myasthenia gravis, a model of organ-specific autoimmune disease.
    Berrih-Aknin S.
    J Autoimmun; 1995 Apr 01; 8(2):139-43. PubMed ID: 7612144
    [Abstract] [Full Text] [Related]

  • 17. Myasthenia gravis: antibodies to acetylcholine receptor with human and rat antigens.
    Oda K, Goto I, Kuroiwa Y, Onoue K, Ito Y.
    Neurology; 1980 May 01; 30(5):543-6. PubMed ID: 7189261
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.